Status:
COMPLETED
Injection of Subcutaneous Glucose 10% in Small Shots is Effective in the Treatment of Diabetic Neuropathic Pain
Lead Sponsor:
Ministry of Health and Population, Egypt
Conditions:
Painful Diabetic Neuropathy
Eligibility:
All Genders
20-50 years
Brief Summary
Observational cohort prospective study with the following of 100 patients of type 1 and type 2 diabetes mellitus in 2 groups each group 50 patients, each group 30 males, and 20 females,35 patients wit...
Detailed Description
Observational cohort prospective study with the following of 100 patients of type 1 and type 2 diabetes mellitus in 2 groups each group 50 patients, each group 30 males, and 20 females,35 patients wit...
Eligibility Criteria
Inclusion
- patients 20 years to 50 years with type 1 or type 2 diabetes who have symptoms of symmetrical peripheral neuropathic pain.
- female Patients are not pregnant.
- Patient has a pain score of at least 5 on the Visual Analogue Scale (VAS).
- Patients are on their antidiabetes medication.
- patents are not on any medication for peripheral neuropathy.
- Patient must be able to complete questions on the Michigan Neuropathy Screening Instrument (MNSI).
Exclusion
- Patient has conditions that could affect the evaluation of painful DPN, or non-diabetic neurologic disorders.
- Patient has skin conditions in the area affected by the neuropathy that could alter sensation.
- Patient with history of drug abuse.
- patients on any drug for diabetic neuropathy like pregabalin or gabapentin. No side effects were monitored during the period of treatment.
Key Trial Info
Start Date :
July 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 9 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04097691
Start Date
July 14 2019
End Date
October 9 2019
Last Update
May 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mahmoud Younis
Cairo, Egypt, 11759